Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
To view or add a comment, sign in Today in #Employer Coverage: CMS has indefinitely postponed its BALANCE program that would have subsidized #GLP-1 obesity medications for Medicare members, a predictable outcome given the adverse selection risks and short-term cost challenges that make coverage financially untenable for health plans even at negotiated prices
Losing progress on your tirzepatide weight loss timeline due to a provider system change is understandably frustrating
They can check if you really need the drug and find other options
Promotes longer-lasting fullness and better portion control
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
